Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma is a research paper published in Transplantation and Cellular Therapy (2021). On theSindex it has a DataRank of 0.373. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Health Resources and Services Administration
Grant: N00014-20-1-2832
Health Resources and Services Administration
Grant: N00014-20-1-2705
National Institutes of Health
Grant: R01 HL130388
National Institutes of Health
Grant: R01 AI128775
National Institute of Allergy and Infectious Diseases
Grant: HHSH250201700006C
Novartis
Grant: EcoR1
NCI NIH HHS
Grant: P30 CA008748
National Institutes of Health
Grant: U24CA076518
NHLBI NIH HHS
Grant: U10 HL069294
Amgen
Bayer Fund
Bristol-Myers Squibb
Novartis Pharmaceuticals Corporation
Celgene
National Cancer Institute
Karyopharm Therapeutics
Kiadis Pharma
Merck Sharp and Dohme
Astellas Pharma US
GlaxoSmithKline
Jazz Pharmaceuticals
Daiichi-Sankyo
Government of South Australia
Office of Naval Research
U.S. Department of Defense
Biomedical Advanced Research and Development Authority
CSL Behring
National Heart, Lung, and Blood Institute
U.S. Navy
Angiocrine Bioscience
Takeda Pharmaceutical Company
U.S. Public Health Service
FWCI
1.28
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals